Raymond James & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $202M | Buy |
|
|||||
|
2024
Q2 | $158M | Buy |
|
|||||
|
2024
Q1 | $149M | Sell |
|
|||||
|
2023
Q4 | $201M | Buy |
|
|||||
|
2023
Q3 | $174M | Buy |
|
|||||
|
2023
Q2 | $158M | Sell |
|
|||||
|
2023
Q1 | $197M | Sell |
|
|||||
|
2022
Q4 | $243M | Sell |
|
|||||
|
2022
Q3 | $184M | Buy |
|
|||||
|
2022
Q2 | $179M | Buy |
|
|||||
|
2022
Q1 | $155M | Buy |
|
|||||
|
2021
Q4 | $182M | Sell |
|
|||||
|
2021
Q3 | $180M | Sell |
|
|||||
|
2021
Q2 | $180M | Buy |
|
|||||
|
2021
Q1 | $160M | Buy |
|
|||||
|
2020
Q4 | $134M | Buy |
|
|||||
|
2020
Q3 | $140M | Buy |
|
|||||
|
2020
Q2 | $129M | Sell |
|
|||||
|
2020
Q1 | $170M | Sell |
|
|||||
|
2019
Q4 | $170M | Sell |
|
|||||
|
2019
Q3 | $171M | Buy |
|
|||||
|
2019
Q2 | $68.9M | Sell |
|
|||||
|
2019
Q1 | $67M | Buy |
|
|||||
|
2018
Q4 | $54.8M | Sell |
|
|||||
|
2018
Q3 | $70.7M | Buy |
|
|||||
|
2018
Q2 | $52.9M | Sell |
|
|||||
|
2018
Q1 | $62.7M | Sell |
|
|||||
|
2017
Q4 | $59.8M | Sell |
|
|||||
|
2017
Q3 | $78.5M | Buy |
|
|||||
|
2017
Q2 | $65.5M | Buy |
|
|||||
|
2017
Q1 | $61M | Buy |
|
|||||
|
2016
Q4 | $63M | Sell |
|
|||||
|
2016
Q3 | $73.4M | Buy |
|
|||||
|
2016
Q2 | $60.6M | Buy |
|
|||||
|
2016
Q1 | $64.1M | Sell |
|
|||||
|
2015
Q4 | $87.3M | Buy |
|
|||||
|
2015
Q3 | $79.6M | Buy |
|
|||||
|
2015
Q2 | $83.7M | Buy |
|
|||||
|
2015
Q1 | $63.5M | Buy |
|
|||||
|
2014
Q4 | $57.1M | Buy |
|
|||||
|
2014
Q3 | $53.8M | Buy |
|
|||||
|
2014
Q2 | $40.1M | Buy |
|
|||||
|
2014
Q1 | $21.8M | Buy |
|
|||||
|
2013
Q4 | $20.7M | Buy |
|
|||||
|
2013
Q3 | $15.1M | Sell |
|
|||||
|
2013
Q2 | $14.2M | Buy |
|